Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2010
05/27/2010CA2742947A1 Antioxidant
05/27/2010CA2742946A1 Antioxidant
05/27/2010CA2742023A1 Polar quinazolines as liver x receptors ( lxrs ) modulators
05/27/2010CA2741839A1 1-oxa-8-azaspiro [4,5] decane-8-carboxamide compounds as faah inhibitors
05/27/2010CA2741511A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/27/2010CA2739900A1 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010EP2189453A1 Rocaglaol derivatives as cardioprotectant agents
05/26/2010EP2189449A1 Aminopyrazole amide derivative
05/26/2010EP2188279A2 1,3 and 1,3,5 substituted imidazoles as antihypertensiva
05/26/2010EP2188277A1 Quinazolinedione chymase inhibitors
05/26/2010EP2188263A1 Benzimidazole derivatives used as fxr agonists
05/26/2010EP2188256A1 Renin inhibitors
05/26/2010EP2188015A2 Use of salusin beta alone or in combination with octreotide as a therapeutic agent
05/26/2010EP2187956A2 Use of a laminin peptide as a therapeutic agent
05/26/2010EP2187952A1 Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agents
05/26/2010EP2187950A1 Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agent
05/26/2010EP2187949A2 Use of glp-1 as a therapeutic agent
05/26/2010EP2187948A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187947A2 Use of calcitonin as anti-angiogenic agent
05/26/2010EP2187946A1 Use of a peptide as a therapeutic agent
05/26/2010EP2187934A1 Use of fertirelin and delta-endorphin as therapeutic agents
05/26/2010EP2187931A2 Use of a combination of cart peptides as a therapeutic agent
05/26/2010EP2187930A2 Trap-14 as a therapeutic agent
05/26/2010EP2187929A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187924A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187917A2 Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agent
05/26/2010EP2187915A2 Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent
05/26/2010EP2187909A1 Use of bpp-b as a therapeutic agent
05/26/2010EP2187907A2 Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
05/26/2010EP2187896A2 Micro-rnas that control myosin expression and myofiber identity
05/26/2010EP2187890A1 Method for reducing intracranial pressure
05/26/2010EP1572168B1 Anti-infarction molecules
05/26/2010EP1539137B1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
05/26/2010EP1461325B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/26/2010EP1424998B1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
05/26/2010EP1315709B1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
05/26/2010CN1972931B Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia
05/26/2010CN1970006B Chinese medicinal wine for treating piles and preparation process thereof
05/26/2010CN1969903B Acanthopanax extract for preventing and treating cardiovascular and cerebrovascular disease and preparation process thereof
05/26/2010CN1965898B Compound capsule of red sage root and method for preparing same
05/26/2010CN1935277B Preparation for the prophylaxis of restenosis
05/26/2010CN1935211B Medicinal composition for treating cerebral ischemia
05/26/2010CN1930180B L-saccharide glucose lipid A analogue
05/26/2010CN1922183B Nitrogenous fused heteroaromatic ring derivative
05/26/2010CN1899456B Pile ointment
05/26/2010CN1895546B Lycium chinensis polyose medicinal composition with therapeutic and health-care functions
05/26/2010CN1895353B Preparation of compound Danshen tablets
05/26/2010CN1893932B Microemulsion preconcentrate comprising a renin inhibitor
05/26/2010CN1886150B Fibroblast-mobilizing agent containing G-CSF and wound remedy
05/26/2010CN1875997B Application of sundew in pharmaceutical preparation
05/26/2010CN1871010B Prophylaxis and/or treatment of portal hypertension
05/26/2010CN1831119B Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
05/26/2010CN1803184B Compound dragon's blood medicine
05/26/2010CN1803144B Pharmaceutical composition containing clofibrate compound and B family vitamin
05/26/2010CN1762438B Medicinal composition for treating dizziness with qi-deficiency blood-stasis pattern and preparing process thereof
05/26/2010CN1739549B Preparation process of active medicinal lignin matter and its use in treating cardiac vascular diseases
05/26/2010CN1736384B Mixture of higher primary aliphatic alcohols with acetylsalicylic acid and pharmaceutical formulation
05/26/2010CN1709497B Miao-medicine composition and its use
05/26/2010CN1692914B Application of timosaponin B II for preparing medicine or products for treating and preventing stroke
05/26/2010CN1690057B Selenophen derivatives and their use for prevention and/or treatment of diseases relative to protein aging
05/26/2010CN1681811B Azolidinone-vinyl fused-benzene derivatives
05/26/2010CN1660832B Method for extracting and separating general flavone and saponin astragalus root from astragalus root
05/26/2010CN1656073B Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
05/26/2010CN1646138B Novel therapeutical use of agonist ligands specific to G2A receptor
05/26/2010CN1642580B Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
05/26/2010CN1642538B Use of adapalene for the treatment of dermatological disorders
05/26/2010CN1596313B Humanized collagen antibodies and related methods
05/26/2010CN1553814B Remedies for arteriosclerosis
05/26/2010CN1359390B Factor VII a inhibitors
05/26/2010CN101715448A The therapeutic uses of imidazol-5-carboxylic acid derivatives
05/26/2010CN101712720A Human antibodies that bind human TNF alpha
05/26/2010CN101712706A Intermediate of flavonoid compound and preparation method and application thereof
05/26/2010CN101712705A Intermediate of flavonoid compound and preparation method and application thereof
05/26/2010CN101712704A Method for preparing flavonoid compounds, used intermediate and preparation method thereof
05/26/2010CN101712702A Intermediate of flavonoid compound and preparation method and application thereof
05/26/2010CN101712682A Method for synthesizing tasosartan
05/26/2010CN101712676A Water soluble puerarin derivatives and preparation method and application thereof
05/26/2010CN101712672A Novel compound for treating diseases of cardiovascular and cerebrovascular systems, preparation method and application thereof
05/26/2010CN101712668A Intermediate of flavonoid compound and preparation method and application thereof
05/26/2010CN101712667A Intermediate of flavonoid compound and preparation method and application thereof
05/26/2010CN101712660A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
05/26/2010CN101712642A 5 site-sodium thiosulfate substituted elsinochrome derivative and preparation method and application thereof
05/26/2010CN101712640A methods and compositions for treating amyloid-related diseases
05/26/2010CN101712618A Two crystal form materials of salvianolic acid A, preparation method as well as medicine compound and application thereof
05/26/2010CN101711854A Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases
05/26/2010CN101711853A Traditional Chinese medicine composition for treating symptoms of bradycardia and preparation method thereof
05/26/2010CN101711850A Traditional Chinese medicine composition for treating symptoms of myocardial ischemia, palpitation and severe palpitation and preparation method
05/26/2010CN101711849A Traditional Chinese medicine composition for treating symptoms of qi stasis, blood stasis, myoma and cyst and preparation method
05/26/2010CN101711844A Chinese medicinal composition for relieving stagnation and freeing network vessels
05/26/2010CN101711843A Nerve-calming brain nourishing tea
05/26/2010CN101711837A Traditional Chinese medicine preparation for treating coronary heart diseases and angina pectoris
05/26/2010CN101711828A Decoction for promoting blood circulation
05/26/2010CN101711815A Dripping pill for treating hypertension
05/26/2010CN101711813A Traditional Chinese medicine pill for treating vasculitis
05/26/2010CN101711800A Traditional Chinese medicine compound composition for treating arteriosclerotic cardiovascular diseases and processing method thereof
05/26/2010CN101711793A Medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof
05/26/2010CN101711792A Dripping pill for treating coronary heart diseases and preparation method thereof
05/26/2010CN101711781A Method for extracting and purifying flavonoids compounds by ion-exchange fibers
05/26/2010CN101711771A Heparin derivative polysaccharide mixture and preparation method and medicinal composition thereof
1 ... 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 ... 1595